RT-310 Safety and Feasibility BPH Study

Summary

RT-310, is intended to deliver drug locally to the prostate gland for the management of prostate disease, while minimizing systemic exposure and its associated side-effects. The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.

Timeline

Start

2025-03-13

Primary completion

2026-03

Completion

2026-06

Drugs

Indications